Steatotic liver disease among lean and non-lean individuals in Southern Lao PDR: a cross-sectional study of risk factors

References

• Fan JG, Saibara T, Chitturi S, Asia-Pacific Working Party for N., et al. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? J Gastroenterol Hepatol. 2007;22(6):1–14. doi: 10.1111/j.1440-1746.2007.04952.x.
   PubMed Web of Science ®Google Scholar
• Tilg H, Adolph TE, Dudek M, et al. Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity. Nat Metab. 2021;3(12):1596–1607. doi: 10.1038/s42255-021-00501-9.
   PubMedGoogle Scholar
• Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129(1):113–121. doi: 10.1053/j.gastro.2005.04.014.
   PubMed Web of Science ®Google Scholar
• Pirmoazen AM, Khurana A, El Kaffas A, et al. Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease. Theranostics. 2020;10(9):4277–4289. doi: 10.7150/thno.40249.
   PubMed Web of Science ®Google Scholar
• Li J, Zou B, Yeo YH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in asia, 1999–2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4(5):389–398. doi: 10.1016/s2468-1253(19)30039-1.
   PubMed Web of Science ®Google Scholar
• Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212–2224. doi: 10.1016/S0140-6736(20)32511-3.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. Diabetologia. 2016;59(6):1121–1140. doi: 10.1007/s00125-016-3902-y.
   PubMed Web of Science ®Google Scholar
• Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science. 2011;332(6037):1519–1523. doi: 10.1126/science.1204265.
   PubMed Web of Science ®Google Scholar
• Wu X, Wang Y, Jia Y, et al. Risk factors for nonalcoholic fatty liver disease with different insulin resistance in a nonobese chinese population. J Diabetes Res. 2022;2022:9060405–9060410. doi: 10.1155/2022/9060405.
   PubMed Web of Science ®Google Scholar
• Barba C, Cavalli-Sforza T, Cutter J, Darnton-Hill I, Deurenberg P, Deurenberg-Yap M, et al. Appropriate body-mass index for asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–163. doi: 10.1016/s0140-6736(03)15268-3.
   Google Scholar
• Xu R, Pan J, Zhou W, et al. Recent advances in lean NAFLD. Biomed Pharmacother. 2022;153:113331. doi: 10.1016/j.biopha.2022.113331.
   PubMed Web of Science ®Google Scholar
• Andrews RH, Sithithaworn P, Petney TN. Opisthorchis viverrini: an underestimated parasite in world health. Trends Parasitol. 2008;24(11):497–501. doi: 10.1016/j.pt.2008.08.011.
   PubMed Web of Science ®Google Scholar
• Htun NSN, Odermatt P, Paboriboune P, et al. Association between helminth infections and diabetes mellitus in adults from the Lao People’s Democratic Republic: a cross-sectional study. Infect Dis Poverty. 2018;7(1):105. doi: 10.1186/s40249-018-0488-2.
   PubMedGoogle Scholar
• Ayé Soukhathammavong P, Rajpho V, Phongluxa K, et al. Subtle to severe hepatobiliary morbidity in Opisthorchis viverrini endemic settings in Southern laos. Acta Trop. 2015;141(Pt B):303–309. doi: 10.1016/j.actatropica.2014.09.014.
   PubMedGoogle Scholar
• Kim JY, Yong TS, Rim HJ, et al. Ultrasonographic investigation of cholangiocarcinoma in lao PDR. Acta Trop. 2018;182:128–134. doi: 10.1016/j.actatropica.2018.02.031.
   PubMed Web of Science ®Google Scholar
• Thinkhamrop K, Khuntikeo N, Phonjitt P, et al. Association between diabetes mellitus and fatty liver based on ultrasonography screening in the world’s highest cholangiocarcinoma incidence region, northeast Thailand. Asian Pac J Cancer Prev. 2015;16(9):3931–3936. doi: 10.7314/apjcp.2015.16.9.3931.
   PubMedGoogle Scholar
• Suwimol S, Pisit T, Anchalee A, et al. Neck circumference as a screening measure for identifying NAFLD among a group of academic employees in bangkok, Thailand. PLoS One. 2022;17(2):e0263826. doi: 10.1371/journal.pone.0263826.
   PubMed Web of Science ®Google Scholar
• Ministry of Health Lao PDR. A diagnosis and treatment guideline for the district hospital in lao PDR. In Vientiane ministry of health. 2nd ed. 2004.
   Google Scholar
• Sripa B, Thinkhamrop B, Mairiang E, et al. Elevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini. PLoS Negl Trop Dis. 2012;6(5):e1654. doi: 10.1371/journal.pntd.0001654.
   PubMed Web of Science ®Google Scholar
• Strauss S, Gavish E, Gottlieb P, et al. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol. 2007;189(6):W320–W3. doi: 10.2214/AJR.07.2123.
   PubMed Web of Science ®Google Scholar
• Katz N, Chaves A, Pellegrino J. A simple, device for quantita tive stool thick-smear technique in schistosomiasis mansoni. Revista Do Instituto de Medicina Tropical de Sao Paulo. 1972;14(6):397–400.
   PubMedGoogle Scholar
• National Institue of Diabetes and Digestive and Kidney Diseases. List of NGSP Certified Methods. 2020. https://www.niddk.nih.gov/-/media/Files/News/NGSP-certified.pdf.
   Google Scholar
• Aschner P. New IDF clinical practice recommendations for managing type 2 diabetes in primary care. Diabetes Res Clin Pract. 2017;132:169–170. doi: 10.1016/j.diabres.2017.09.002.
   PubMed Web of Science ®Google Scholar
• Vonghachack Y, Odermatt P, Taisayyavong K, et al. Transmission of Opisthorchis viverrini, schistosoma mekongi and soil-transmitted helminthes on the mekong islands, Southern lao PDR. Infect Dis Poverty. 2017;6(1):131. doi: 10.1186/s40249-017-0343-x.
   PubMedGoogle Scholar
• Takamiya T, Zaky WR, Edmundowics D, et al. World health organization-defined metabolic syndrome is a better predictor of coronary calcium than the adult treatment panel III criteria in American men aged 40–49 years. Diabetes Care. 2004;27(12):2977–2979. doi: 10.2337/diacare.27.12.2977.
   PubMed Web of Science ®Google Scholar
• Wong MCS, Huang JLW, George J, et al. The changing epidemiology of liver diseases in the Asia-Pacific region. Nat Rev Gastroenterol Hepatol. 2019;16(1):57–73. doi: 10.1038/s41575-018-0055-0.
   PubMed Web of Science ®Google Scholar
• Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67(1):328–357. doi: 10.1002/hep.29367.
   PubMed Web of Science ®Google Scholar
• Young S, Tariq R, Provenza J, et al. Prevalence and profile of nonalcoholic fatty liver disease in lean adults: systematic review and meta-analysis. Hepatol Commun. 2020;4(7):953–972. doi: 10.1002/hep4.1519.
   PubMed Web of Science ®Google Scholar
• Chaidee A, Onsurathum S, Intuyod K, et al. Opisthorchis viverrini infection augments the severity of nonalcoholic fatty liver disease in high-fat/high-Fructose diet-Fed hamsters. Am J Trop Med Hyg. 2019;101(5):1161–1169. doi: 10.4269/ajtmh.19-0442.
   PubMed Web of Science ®Google Scholar
• Kaewpitoon SJ, Rujirakul R, Wakkuwattapong P, et al. Overweight relation to liver fluke infection among rural participants from 4 districts of nakhon ratchasima province, Thailand. Asian Pac J Cancer Prev. 2016;17(5):2565–2571. doi: 10.7314/APJCP.2016.17.5.2565.
   PubMedGoogle Scholar
• Liu X, Jiang Y, Ye J, et al. Helminth infection and helminth-derived products: a novel therapeutic option for non-alcoholic fatty liver disease. Front Immunol. 2022;13:999412. doi: 10.3389/fimmu.2022.999412.
   PubMed Web of Science ®Google Scholar
• Muthukumar R, Suttiprapa S, Mairiang E, et al. Effects of Opisthorchis viverrini infection on glucose and lipid profiles in human hosts: a cross-sectional and prospective follow-up study from Thailand. Parasitol Int. 2020;75:102000. doi: 10.1016/j.parint.2019.102000.
   PubMed Web of Science ®Google Scholar
• Liu L, Li H, Zhang Y, et al. Hepatitis B virus infection combined with nonalcoholic fatty liver disease: interaction and prognosis. Heliyon. 2023;9(1):e13113. doi: 10.1016/j.heliyon.2023.e13113.
   PubMed Web of Science ®Google Scholar
• Wang CC, Cheng PN, Kao JH. Systematic review: chronic viral hepatitis and metabolic derangement. Aliment Pharmacol Ther. 2020;51(2):216–230. doi: 10.1111/apt.15575.
   PubMed Web of Science ®Google Scholar
• Joo EJ, Chang Y, Yeom JS, et al. Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: a cohort study. Hepatology. 2017;65(3):828–835. doi: 10.1002/hep.28917.
   PubMed Web of Science ®Google Scholar
• Yu MW, Lin CL, Liu CJ, et al. Hepatic steatosis and development of type 2 diabetes: impact of chronic hepatitis B and viral specific factors. J Formos Med Assoc. 2022;121(8):1478–1487. doi: 10.1016/j.jfma.2021.10.014.
   PubMed Web of Science ®Google Scholar
• Duseja A, De A, Wong V. Special population: lean nonalcoholic fatty liver disease. Clin Liver Dis. 2023;27(2):451–469. doi: 10.1016/j.cld.2023.01.011.
   PubMed Web of Science ®Google Scholar
• Akhtar DH, Iqbal U, Vazquez-Montesino LM, et al. Pathogenesis of insulin resistance and atherogenic dyslipidemia in nonalcoholic fatty liver disease. J Clin Transl Hepatol. 2019;7(4):362–370. doi: 10.14218/JCTH.2019.00028.
   PubMed Web of Science ®Google Scholar
• Yang L, Yang C, Thomes PG, et al. Lipophagy and alcohol-Induced fatty liver. Front Pharmacol. 2019;10:495. doi: 10.3389/fphar.2019.00495.
   PubMed Web of Science ®Google Scholar
• Idalsoaga F, Kulkarni AV, Mousa OY, et al. Non-alcoholic fatty liver disease and alcohol-related liver disease: two intertwined entities. Front Med (Lausanne). 2020;7:448. doi: 10.3389/fmed.2020.00448.
   PubMed Web of Science ®Google Scholar
• Kim JY, Yi K, Kang M, et al. Comparison of dietary behavior, changes of diet, and food intake between 40 ∼ 59 years old subjects living in urban and rural areas in lao PDR. J Nutr Health. 2016;49(2):111. doi: 10.4163/jnh.2016.49.2.111.
   Google Scholar
• Vonglokham M, Kounnavong S, Sychareun V, et al. Prevalence and social and health determinants of pre-diabetes and diabetes among adults in laos: a cross-sectional national population-based survey, 2013. Trop Med Int Health. 2019;24(1):65–72. doi: 10.1111/tmi.13164.
   PubMed Web of Science ®Google Scholar
• Almomani A, Kumar P, Onwuzo S, et al. Epidemiology and prevalence of lean nonalcoholic fatty liver disease and associated cirrhosis, hepatocellular carcinoma, and cardiovascular outcomes in the United States: a population‐based study and review of literature. J Gastroenterol Hepatol. 2023;38(2):269–273. doi: 10.1111/jgh.16049.
   PubMed Web of Science ®Google Scholar
• Miyano S, Pathammavong C, Ichimura Y, et al. Prevalence of hepatitis B and C virus infections in Lao People’s Democratic Republic: the first national population-based cross-sectional survey. PLoS One. 2022;17(12):e0278933. doi: 10.1371/journal.pone.0278933.
   PubMed Web of Science ®Google Scholar